Preview

Endocrine Surgery

Advanced search

Clinical and laboratory characteristics of patients with type 2 diabetes and diabetic foot syndrome

https://doi.org/10.14341/serg12799

Abstract

Background: Diabetes mellitus (DM) is one of the most common chronic diseases, leading to the development of many complications includingdiabetic foot syndrome (DFS). The problem of a progressive increase in the number of patients with DFS and the high risk of amputation in the population of patients with DM requires research to identify risk factors and specify ways to correct them.

Aim: To study the clinical and laboratory characteristics of patients of the limb rescue center suffering from type 2 diabetes (DM2).

Materials and Methods: A retrospective analysis of 729 medical histories of patients with T2D hospitalized in the foot rescue department of the limb rescue center of the State Clinical Hospital named after V.P. Demikhov in the period between 2019 and 2020 was carried out. An analysis of anamnestic data, clinical and laboratory parameters, drug therapy, the nature of surgical intervention and the outcome of hospitalization was performed. The statistical analysis was carried out using STATISTICA 8.0.

Results: The study included 729 patients with T2D. Men dominated among patients (58%). The median of age was 66 [59.0; 73.0] years. 50.89% had experience of diabetes for more than 10 years. 53% of these patients had DFS, 79.2% had diabetic polyneuropathy, 45% had previously undergone amputation of the lower extremity, 24.8% had revascularization. A significant proportion of patients at admission had uncontrolled high level of glycemia. The median of glucose level was 9.9 mmol/l [7.2; 13.8]. Median meaning of HbA1c was 7.8% [6.7; 9.1]. BMI and lipid profile were not evaluated in all patients. In the department 224 patients were diagnosed with DFS for the first time. Gangrene prevailed among the ulcerative-necrotic complications of DFS. Arterial hypertension (AH) prevailed among the concomitant pathologies. GFR ˂ 60 ml/min/1.73m2 was observed in 45.36% of patients. According to X-ray data, 27.16%  of patients (107 out of 394) showed signs of impaired bone density. In the department, 113 patients underwent revascularization, 372 — amputation of the lower limb, while 37 patients (9.95%) underwent amputation at the level above the knee, and 335 (90.05%) — at the level below the knee. Only 244 patients received local treatment among patients with DFS. A total of 718 patients were discharged; 11 patients died. The median duration of hospitalization of discharged patients was 13.0 [9.0; 18.0] bed days, the average duration of hospitalization of deceased patients was 11.31±2.21 (95% CI 6.49–16.13) bed days.

Conclusion: Most of the patients with DM2 and DFS had prolonged decompensation of carbohydrate metabolism, dyslipidemia, increased BMI, hypertension. The study concluded that it is important to monitor and correct risk factors to improve the prognosis of the disease.

About the Authors

T. Yu. Demidova
Russian National Research Medical University, Ministry of Health of Russia
Russian Federation

Tatiana Y. Demidova, MD, Professor,

1 Ostrovityanova street, 117997 Moscow



K. G. Lobanova
Russian National Research Medical University, Ministry of Health of Russia

Kristina G. Lobanova,

1 Ostrovityanova street, 117997 Moscow



A. S. Teplova
Russian National Research Medical University, Ministry of Health of Russia

Anna S. Teplova,

1 Ostrovityanova street, 117997 Moscow



I. D. Gurova
Russian National Research Medical University, Ministry of Health of Russia

Irina D. Gurova,

1 Ostrovityanova street, 117997 Moscow



V. E. Bairova
Russian National Research Medical University, Ministry of Health of Russia

Valeriya E. Bairova,

1 Ostrovityanova street, 117997 Moscow



References

1. Global report on diabetes. Geneva: World health organization; 2018.

2. Dedov II, Shestakova MV, Mayorov AY, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY (10th edition). Diabetes mellitus. doi: https://doi.org/10.14341/DM13042

3. National guide edited by academician of the Russian Academy of Sciences II Dedov, academician of the Russian Academy of Sciences GA Melnichenko, 2nd edition, Moscow, 2020

4. Bandyk DF. The diabetic foot: Pathophysiology, evaluation, and treatment. Semin Vasc Surg. 2018. Jun-Dec;31(2-4):43-48. doi: https://doi.org/10.1053/j.semvascsurg.2019.02.001

5. Van Battum P, Schaper N, Prompers L, et. al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Med. J. Br. Diabet. Assoc. 2011;28:199-205. doi: https://doi.org/10.1111/j.1464-5491.2010.03192.x

6. Galstyan GR, Vikulova OK, Isakov MA, et al. Epidemiology of diabetic foot syndrome and lower limb amputations in the Russian Federation according to the Federal Register of Patients with Diabetes (2013-2016) // Diabetes mellitus. 2018;21(3):170-177. doi: https://doi.org/10.14341/DM9688

7. Sen P, Demirdal T, Emir B. Meta-analysis of risk factors for amputation in diabetic foot infections. Diabetes Metab Res Rev. 2019;35(7):e3165. doi: https://doi.org/10.1002/dmrr.3165

8. Wukich DK, Raspovic KM. Assessing health-related quality of life in patients with diabetic foot disease: Why is it important and how can we improve? The 2017 Roger E. Pecoraro award lecture. Diabetes Care 2018;41:391-397

9. Yelsukova OS, Vlasikhina EN. Frequency of risk factors for atherosclerosis in patients with type 2 diabetes depending on the presence of diabetic foot syndrome. Vyatka Medical Bulletin, 2007. №1

10. Lin C, Liu J, Sun H. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A meta-analysis. PLoS One. 2020;16;15(9):e0239236. doi: https://doi.org/10.1371/journal.pone.0239236

11. Yelsukova OS, Vlasikhina EN. Prevalence of arterial hypertension and efficacy of antihypertensive therapy in patients with type 2 diabetes depending on the presence of diabetic foot syndrome // Vyatka Medical Journal. — 2007. — №1

12. Onuchin SG, Yelsukova OS, Onuchina EL. Risk factors for diabetic foot syndrome and the possibilities of complex sugar-lowering, antihypertensive and hypolipidemic therapy // PM. — 2008. — №27

13. Walton DV, Edmonds ME, Bates M, et. al. People living with diabetes are unaware of their foot risk status or why they are referred to a multidisciplinary foot team. J Wound Care. 2021;30(8):598-603. doi: https://doi.org/10.12968/jowc.2021.30.8.598

14. Rossboth S, Lechleitner M, Oberaigner W. Risk factors for diabetic foot complications in type 2 diabetes-A systematic review. Endocrinol Diabetes Metab. 2020;4(1):e00175. doi: https://doi.org/10.1002/edm2.175

15. Liu J, Yuan X, Liu J, et al. Risk Factors for Diabetic Peripheral Neuropathy, Peripheral Artery Disease, and Foot Deformity Among the Population With Diabetes in Beijing, China: A Multicenter, Cross-Sectional Study. Front Endocrinol (Lausanne). 2022;13:824215. doi: https://doi.org/10.3389/fendo.2022.824215

16. McDermott K, Fang M, Boulton AJM, et al. Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care. 2023;46(1):209-221. doi: https://doi.org/10.2337/dci22-0043

17. Lewis S, Raj D, Guzman NJ. Renal failure: implications of chronic kidney disease in the management of the diabetic foot. Semin Vasc Surg. 2012;25(2):82-8. doi: https://doi.org/10.1053/j.semvascsurg.2012.04.007

18. Huang ZH, Li S, Kou Y, et al. Risk Factors for the Recurrence of Diabetic Foot Ulcers Among Diabetic Patients: A Meta-Analysis. Int Wound J 2019;16:1373-82. doi: https://doi.org/10.1111/iwj.13200

19. Chenyang Q, Xing M, Zhigang Z, et al. Classification and Differential Diagnosis of Diabetic Nephropathy. Journal of Diabetes Research, vol.2017, Article ID 8637138, 7 pages, 2017. doi: https://doi.org/10.1155/2017/8637138

20. Tonneijck L, Muskiet M, Smits M, et al. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol. 2017;28(4):1023-1039. doi: https://doi.org/10.1681/ASN.2016060666

21. Cachat F, Combescure C, Cauderay M, et al. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clin J Am Soc Nephrol. 2015; 6;10(3):382-9. doi: https://doi.org/10.2215/CJN.03080314

22. Molitvoslovova NA, Galstyan GR. Osteoporosis and diabetes mellitus: a modern viewpoint. Diabetes mellitus. 2013;16(1):57-62. (In Russ.). doi: https://doi.org/10.14341/2072-0351-3598

23. Kang L, Chen Q, Wang L, et al. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol. 2009;36(10):e47-56. doi: https://10.1111/j.1440-1681.2009.05219.x

24. Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21(2):195-214. doi: https://doi.org/10.1007/s00198-009-1066-z

25. Roikjer J, Jensen MH, Vestergaard P, et al. Twenty years with diabetes and amputations: a retrospective populationbased cohort study. Diabet Med. 2020;37(12):2098-2108. doi: https://doi.org/10.1111/dme.14251

26. Boyko E, Seelig A, Ahroni J. Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study. Diabetes Care. 2018;41(4):891-898. doi:https://doi.org/10.2337/dc17-2210


Supplementary files

1. Рисунок 1. Дизайн включения пациентов в ретроспективный анализ.
Subject
Type Other
View (153KB)    
Indexing metadata ▾
2. Рисунок 2. СДС у пациентов с СД2, госпитализированных в центр спасения конечностей.
Subject
Type Other
View (167KB)    
Indexing metadata ▾
3. Рисунок 3. Гнойно-некротические осложнения у пациентов с СДС, госпитализированных в центр спасения конечностей.
Subject
Type Other
View (128KB)    
Indexing metadata ▾
4. Рисунок 4. Структура сопутствующей патологии среди пациентов с СД2, госпитализированных в центр спасения конечностей.
Subject
Type Other
View (162KB)    
Indexing metadata ▾

Review

For citations:


Demidova T.Yu., Lobanova K.G., Teplova A.S., Gurova I.D., Bairova V.E. Clinical and laboratory characteristics of patients with type 2 diabetes and diabetic foot syndrome. Endocrine Surgery. 2023;17(4):13-20. (In Russ.) https://doi.org/10.14341/serg12799

Views: 588


ISSN 2306-3513 (Print)
ISSN 2310-3965 (Online)